MJ Griffiths, M Messent, NP Curzen and TW Evans
Unit of Critical Care, National Heart and Lung Institute, London, United Kingdom.

Overproduction of nitric oxide (NO) following induction of NO synthase in vascular smooth muscle by endotoxin and certain cytokines contributes to the vasodilation and hyporesponsiveness to vasopressors that characterize the septic circulation. Guanosine 3',5'-cyclic monophosphate (cGMP) mediates the effects of NO in vascular smooth muscle. Vessels from animals treated with endotoxin have elevated cGMP levels compared with control animals. Aminoguanidine has been proposed as a selective inhibitor of the inducible form of NO synthase. This study compares the effects of aminoguanidine on phenylephrine-induced contractions and cGMP levels in thoracic aortic rings from endotoxin treated (20 mg/kg intraperitoneally) with sham-treated (1 ml saline intraperitoneally) rats. Endotoxin-treatment depressed phenylephrine- induced contraction and raised tissue levels of cGMP. Aminoguanidine (100 microM and 1 mM) increased phenylephrine-induced tension and decreased cGMP levels in a dose-dependent manner in intact and endothelium-denuded aortas from endotoxin-treated rats but had no effect on vessels from sham-treated rats. These findings are consistent with the hypothesis that endotoxin treatment causes increased vascular production of endothelium-independent NO, which is associated with a diminished response to vasoconstrictors. Aminoguanidine decreases indices of NO production only after endotoxin treatment, providing further evidence that it is a selective inhibitor of inducible NO synthase.

This article has been cited by other articles:

				J. Yang, R. Ji, Y. Cheng, J.-Z. Sun, L. K. Jennings, and C. Zhang L-Arginine Chlorination Results in the Formation of a Nonselective Nitric-Oxide Synthase Inhibitor J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1044 - 1049. [Abstract] [Full Text] [PDF]

				S. A. Nasraway The Problems and Challenges of Immunotherapy in Sepsis Chest, May 1, 2003; 123(5_suppl): 451S - 459S. [Abstract] [Full Text] [PDF]

				K. Naoki, H. Kudo, K. Suzuki, K. Takeshita, N. Miyao, M. Ishii, N. Sato, Y. Suzuki, H. Tsumura, and K. Yamaguchi NOS and COX isoforms and abnormal microvessel responses to CO2 and H+ in hyperoxia-injured lungs Eur. Respir. J., July 1, 2002; 20(1): 43 - 51. [Abstract] [Full Text] [PDF]

				S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc Res, August 15, 1999; 43(3): 698 - 711. [Abstract] [Full Text] [PDF]

				K. B. Jourdan, T. W. Evans, N. J. Lamb, P. Goldstraw, and J. A. Mitchell Autocrine Function of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Proliferation of Human and Rat Pulmonary Artery Smooth-Muscle Cells . Species Variation Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 105 - 110. [Abstract] [Full Text]

				K. SUZUKI, K. NAOKI, H. KUDO, K. NISHIO, N. SATO, T. AOKI, Y. SUZUKI, K. TAKESHITA, A. MIYATA, H. TSUMURA, et al. Impaired Hypoxic Vasoconstriction in Intraacinar Microvasculature in Hyperoxia-exposed Rat Lungs Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 602 - 609. [Abstract] [Full Text] [PDF]

				H. SCHÜTTE, K. MAYER, T. GESSLER, M. RÜHL, J. SCHLAUDRAFF, H. BURGER, W. SEEGER, and F. GRIMMINGER Nitric Oxide Biosynthesis in an Exotoxin-induced Septic Lung Model . Role of cNOS and Impact on Pulmonary Hemodynamics Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 498 - 504. [Abstract] [Full Text]